tiprankstipranks
Shanghai Henlius Initiates Japanese Study for Cancer Treatment
PremiumCompany AnnouncementsShanghai Henlius Initiates Japanese Study for Cancer Treatment
4d ago
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
Premium
Company Announcements
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
19d ago
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
Premium
Company Announcements
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
19d ago
Shanghai Henlius Partners with Sandoz for Global Commercialization of HLX13
PremiumCompany AnnouncementsShanghai Henlius Partners with Sandoz for Global Commercialization of HLX13
2M ago
Shanghai Henlius Biotech Advances Phase 3 Trial for Cancer Treatment
Premium
Company Announcements
Shanghai Henlius Biotech Advances Phase 3 Trial for Cancer Treatment
2M ago
Shanghai Henlius Biotech Partners with Alvogen Korea for Cancer Drug Commercialization
Premium
Company Announcements
Shanghai Henlius Biotech Partners with Alvogen Korea for Cancer Drug Commercialization
2M ago
Shanghai Henlius Biotech’s HLX11 Biosimilar Gains EMA Validation
PremiumCompany AnnouncementsShanghai Henlius Biotech’s HLX11 Biosimilar Gains EMA Validation
3M ago
Shanghai Henlius Advances Phase 3 Trial of HLX22 in Japan
Premium
Company Announcements
Shanghai Henlius Advances Phase 3 Trial of HLX22 in Japan
3M ago
Shanghai Henlius Biotech Advances in Autoimmune Treatment with Phase 2 Trial Approval
Premium
Company Announcements
Shanghai Henlius Biotech Advances in Autoimmune Treatment with Phase 2 Trial Approval
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100